Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 6, 2009, Pages 1126-1129

  Johannessen, Asgeir ^a   Trøseid, Marius ^a   Calmy, Alexandra ^b,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c Campaign for Access to Essential Medicines   (Switzerland)

Author keywords

Antiretroviral therapy; Drug resistance; HIV Infections

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIVIRAL RESISTANCE; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; DRIED BLOOD SPOT; DRUG EFFICACY; DRUG MONITORING; DRUG TREATMENT FAILURE; GENOTYPE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; NEWBORN SCREENING; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; SENSITIVITY AND SPECIFICITY; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS LOAD; VIRUS MUTATION; WORLD HEALTH ORGANIZATION; BLOOD; DESICCATION; LABORATORY DIAGNOSIS; METHODOLOGY; REVIEW; TREATMENT OUTCOME; VIROLOGY;

ANTI-HIV AGENTS; BLOOD; DESICCATION; DRUG MONITORING; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HUMANS; SPECIMEN HANDLING; TREATMENT OUTCOME; VIRAL LOAD;

EID: 76249126232     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp353     Document Type: Article

References (36)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). Report on the Global AIDS Epidemic 2008. Geneva: UNAIDS, 2008.
2. Medecins Sans Frontieres (MSF). Untangling the Web of Antiretroviral Price Reductions, 11th Edition, July 2008. Geneva: MSF, 2008.
3. Hammer SM, Eron JJ Jr, Reiss P et al. Antiretroviral treatment ofadult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008; 300: 555-70.
4. Mei JV, Alexander JR, Adam BW et al. Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr 2001; 131: 1631S-6S.
5. Brambilla D, Jennings C, Aldrovandi G et al. Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. J Clin Microbiol 2003; 41: 1888-93.
6. Buckton AJ, Prabhu DP, Cane PA et al. No evidence for crosscontamination of dried blood spots excised using an office hole-punch for HIV-1 drug resistance genotyping. J Antimicrob Chemother 2009; 63: 615-6.
7. Patton JC, Akkers E, Coovadia AH et al. Evaluation of dried whole blood spots obtained by heel or finger stick as an alternative to venous blood for diagnosis of human immunodeficiency virus type 1 infection in vertically exposed infants in the routine diagnostic laboratory. Clin Vaccine Immunol 2007; 14: 201-3.
8. World Health Organization (WHO). Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach, 2006 Revision. Geneva: WHO, 2006.
9. Mee P, Fielding KL, Charalambous S et al. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS 2008; 22: 1971-7.
10. Dineva MA, Candotti D, Fletcher-Brown F et al. Simultaneous visual detection of multiple viral amplicons by dipstick assay. J Clin Microbiol 2005; 43: 4015-21.
11. Fiscus SA, Brambilla D, Grosso L et al. Quantitation of human immunodeficiency virus type 1 RNA in plasma by using blood dried on filter paper. J Clin Microbiol 1998; 36: 258-60.
12. Marconi A, Balestrieri M, Comastri G et al. Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens. Clin Microbiol Infect 2009; 15: 93-7.
13. Garrido C, Zahonero N, Corral A et al. Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests. J Clin Microbiol 2009; 47: 1031-6.
14. Johannessen A, Garrido C, Zahonero N et al. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania. Clin Infect Dis 2009; 49: 976-81.
15. Leelawiwat W, Young NL, Chaowanachan T et al. Dried blood spots for the diagnosis and quantitation of HIV-1: stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand. J Virol Methods 2009; 155: 109-17.
16. Garrido C, Zahonero N, Fernandes D et al. Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola. J Antimicrob Chemother 2008; 61: 694-8.
17. Masciotra S, Garrido C, Youngpairoj AS et al. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients. AIDS 2007; 21: 2503-11.
18. McNulty A, Jennings C, Bennett D et al. Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. J Clin Microbiol 2007; 45: 517-21.
19. Bertagnolio S, Soto-Ramirez L, Pilon R et al. HIV-1 drug resistance surveillance using dried whole blood spots. Antivir Ther 2007; 12: 107-13.
20. Hallack R, Doherty LE, Wethers JA et al. Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay. J Clin Virol 2008; 41: 283-7.
21. Johannessen A, Holberg-Petersen M, Lövgården G et al. Monitoring of HIV-1 drug resistance on dried blood spots is feasible and reliable in patients on antiretroviral therapy in rural Tanzania. In: Abstracts of the Fifth International AIDS Society Conference on HIV Pathogenesis, Prevention and Treatment, Cape Town, South Africa, 2009. Abstract WEPEB210. International AIDS Society, Geneva, Switzerland.
22. Bennett DE, Myatt M, Bertagnolio S et al. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir Ther 2008; 13 Suppl 2: 25-36.
23. Somi GR, Kibuka T, Diallo K et al. Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania. Antivir Ther 2008; 13 Suppl 2: 77-82.
24. Kamoto K, Berle-Grasse J. Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi. Antivir Ther 2008; 13 Suppl 2: 83-7.
25. Sutcliffe CG, van Dijk JH, Bolton C et al. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis 2008; 8: 477-89.
26. Stevens W, Sherman G, Downing R et al. Role of the laboratory in ensuring global access to ARV treatment for HIV-infected children: consensus statement on the performance of laboratory assays for early infant diagnosis. Open AIDS J 2008; 2: 17-25.
27. Sherman GG, Stevens G, Jones SA et al. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J Acquir Immune Defic Syndr 2005; 38: 615-7.
28. Violari A, Cotton MF, Gibb DM et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008; 359: 2233-44.
29. Waters L, Kambugu A, Tibenderana H et al. Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr 2007; 46: 590-3.
30. Monleau M, Montavon C, Laurent C et al. Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing. J Clin Microbiol 2009; 47: 1107-18.
31. Bruisten S, van Gemen B, Koppelman M et al. Detection of HIV-1 distribution in different blood fractions by two nucleic acid amplification assays. AIDS Res Hum Retroviruses 1993; 9: 259-65.
32. van Gemen B, Wiel P, van Beuningen R et al. The one-tube quantitative HIV-1 RNA NASBA: precision, accuracy, and application. PCR Methods Appl 1995; 4: S177-84.
33. Buckton AJ, Bissett SL, Myers RE et al. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance. J Antimicrob Chemother 2008; 62: 1191-8.
34. Steegen K, Luchters S, Demecheleer E et al. Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots. J Clin Microbiol 2007; 45: 3342-51.
35. Youngpairoj AS, Masciotra S, Garrido C et al. HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4°C. J Antimicrob Chemother 2008; 61: 1217-20.
36. Garcia-Lerma JG, McNulty A, Jennings C et al. Rapid decline in the efficiency of HIV drug resistance genotyping from dried blood spots (DBS) and dried plasma spots (DPS) stored at 37°C and high humidity J Antimicrob Chemother 2009; 64: 33 6.